Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Rank in Stocks #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Share Price
$51.99
Market Cap
$104.42B
Change (1 day)
0.29%
Change (1 year)
32.49%
Country
GB
Trade GSK plc (GSK)

Category

Operating Margin for GSK plc (GSK)
Operating Margin as of March 2026 TTM: 21.95%
According to GSK plc latest financial reports and stock price the company's current Operating Margin (TTM) is 21.95%. At the end of 2024 the company had an Operating Margin of 18.05%.
Operating Margin history for GSK plc from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 21.95% 0.00%
2025 21.95% 21.61%
2024 18.05% -21.73%
2023 23.06% 1.18%
2022 22.79% 4.11%
2021 21.89% -8.79%
2020 24.00% 4.08%
2019 23.06% -11.14%
2018 25.95% -1.78%
2017 26.42% 7.88%
2016 24.49% 31.31%
2015 18.65% -12.40%
2014 21.29% -21.58%
2013 27.15% 10.55%
2012 24.56% -11.72%
2011 27.82% 58.61%
2010 17.54% -41.06%
2009 29.76% -6.09%
2008 31.69% -3.44%
2007 32.82% 1.61%
2006 32.30% 7.45%
2005 30.06% 8.83%
2004 27.62% -7.13%
2003 29.74% 13.64%
2002 26.17% -11.94%
2001 29.72% 13.61%
2000 26.16% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
45.56% -97.92%
US
23.28% -98.94%
GB
27.17% -98.76%
US
26.72% -98.78%
US
31.24% -98.58%
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.